Meanwhile, irregular menstruation was significantly linked with increased DUSP1 methylation only in patients with ER-positive (OR 3.564, 95% CI 1.691–7.511) and PR-positive (OR 3.902, 95% CI 1.656–9.194) breast cancer. Here, DUSP1 is linked to breast carcinoma.